104 related articles for article (PubMed ID: 15779804)
1. Susceptibility to infectious rash illness in pregnant women from diverse geographical regions.
Knowles SJ; Grundy K; Cahill I; Cafferkey MT
Commun Dis Public Health; 2004 Dec; 7(4):344-8. PubMed ID: 15779804
[TBL] [Abstract][Full Text] [Related]
2. [Seroprevalence of rubella virus, varicella zoster virus, cytomegalovirus and parvovirus B19 among pregnant women in the Sousse region, Tunisia].
Hannachi N; Marzouk M; Harrabi I; Ferjani A; Ksouri Z; Ghannem H; Khairi H; Hidar S; Boukadida J
Bull Soc Pathol Exot; 2011 Feb; 104(1):62-7. PubMed ID: 21243459
[TBL] [Abstract][Full Text] [Related]
3. Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy).
Morgan-Capner P; Crowcroft NS;
Commun Dis Public Health; 2002 Mar; 5(1):59-71. PubMed ID: 12070980
[TBL] [Abstract][Full Text] [Related]
4. Risk of perinatal transmission of rubella and parvovirus B19 in Jordanian pregnant women.
Bdour S
Vaccine; 2006 Apr; 24(16):3309-12. PubMed ID: 16460842
[TBL] [Abstract][Full Text] [Related]
5. Low cytomegalovirus sero-prevalence in Irish pregnant women.
Knowles SJ; Grundy K; Cahill I; Cafferkey MT; Geary M
Ir Med J; 2005; 98(7):210-2. PubMed ID: 16185018
[TBL] [Abstract][Full Text] [Related]
6. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F
AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
[TBL] [Abstract][Full Text] [Related]
8. Prevention of congenital rubella and congenital varicella in Europe.
Pandolfi E; Chiaradia G; Moncada M; Rava L; Tozzi AE
Euro Surveill; 2009 Mar; 14(9):16-20. PubMed ID: 19317971
[TBL] [Abstract][Full Text] [Related]
9. [Antibodies against vaccine-preventable diseases in pregnant women and their offspring. Measles, mumps, rubella, poliomyelitis, and varicella].
Sauerbrei A; Prager J; Bischoff A; Wutzler P
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jan; 47(1):10-5. PubMed ID: 15205818
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women.
Barlinn R; Vainio K; Samdal HH; Nordbø SA; Nøkleby H; Dudman SG
J Med Virol; 2014 May; 86(5):820-6. PubMed ID: 24114849
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of rubella antibodies among antenatal patients in the Western Cape.
Corcoran C; Hardie DR
S Afr Med J; 2005 Sep; 95(9):688-90. PubMed ID: 16327929
[TBL] [Abstract][Full Text] [Related]
12. Antenatal rubella immunity in Ireland.
O'Dwyer V; Bonham S; Mulligan A; O'Connor C; Farah N; Kennelly MM; Turner MJ
Ir Med J; 2013 Sep; 106(8):232-5. PubMed ID: 24282891
[TBL] [Abstract][Full Text] [Related]
13. Varicella and the pregnant woman: prevention and management.
Daley AJ; Thorpe S; Garland SM
Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):26-33. PubMed ID: 18275568
[TBL] [Abstract][Full Text] [Related]
14. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
Khameneh ZR; Hanifian H; Barzegari R; Sepehrvand N
Indian J Pathol Microbiol; 2014; 57(3):442-4. PubMed ID: 25118740
[TBL] [Abstract][Full Text] [Related]
15. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
van Gessel PH; Gaytant MA; Vossen AC; Galama JM; Ursem NT; Steegers EA; Wildschut HI
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):46-9. PubMed ID: 16406220
[TBL] [Abstract][Full Text] [Related]
16. Infectious immune status in an obstetric population of Pakistani immigrants in Norway.
Bjerke SE; Vangen S; Holter E; Stray-Pedersen B
Scand J Public Health; 2011 Jul; 39(5):464-70. PubMed ID: 21339369
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of rubella-IgG antibody in women of childbearing age in Lagos, Nigeria.
Onyenekwe CC; Kehinde-Agbeyangi TA; Ofor US; Arinola OG
West Afr J Med; 2000; 19(1):23-6. PubMed ID: 10821082
[TBL] [Abstract][Full Text] [Related]
18. [NEW APPROACH IN DIAGNOSTIC ALGORITHM OF AN INFECTIOUS AGENTS (PARVOVIRUS B19 AND CHLAMYDIA TRACHOMATIS) INVOLVED IN THE DEVELOPMENT OF PATHOLOGICAL PREGNANCY].
Voleva S; Ivanova S; Marinov B; Genova-Kalou P; Manolov V; Vasilev V
Akush Ginekol (Sofiia); 2016; 55(3):30-9. PubMed ID: 27514136
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to rubella among pregnant women and the serological evidence of congenital rubella in newborn babies at Colombo South Teaching Hospital.
Weerasekera DS; Fernanado S; Weerasekera MM
Ceylon Med J; 2003 Jun; 48(2):51-3. PubMed ID: 12971208
[TBL] [Abstract][Full Text] [Related]
20. Occupational risk for cytomegalovirus, but not for parvovirus B19 in child-care personnel in France.
de Villemeur AB; Gratacap-Cavallier B; Casey R; Baccard-Longère M; Goirand L; Seigneurin JM; Morand P
J Infect; 2011 Dec; 63(6):457-67. PubMed ID: 21867729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
